2025/2026 - Psychiatry Essentials - When First-Line Fails: Managing Treatment-Resistant Mood Disorders

May 13, 2026

This educational activity provides a comprehensive overview of treatment-resistant mood disorders, with a focus on major depressive disorder and bipolar disorder. Participants will review DSM-5-TR diagnostic criteria, differentiate between depressive and bipolar presentations, and explore common causes of treatment resistance, including pseudo-resistance. The activity emphasizes evidence-based treatment strategies, including pharmacologic optimization, augmentation approaches, and advanced interventions such as ketamine, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT). Practical considerations for evaluation and management in primary care and acute care settings are also discussed.

Target Audience

  • Physicians
  • Residents 

Learning Objectives

Learners will be able to:

  • Summarize the differences between major depressive disorder and bipolar disorder using DSM-5-TR diagnostic criteria and clinical features.
  • Identify treatment-resistant mood disorders and recognize factors contributing to pseudo-resistance and inadequate treatment response.
  • Describe evidence-based management strategies, including pharmacologic augmentation and advanced therapies such as ECT, TMS, and ketamine, for patients with treatment-resistant mood disorders.
Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
05/13/2026
Course expires: 
06/30/2026
Event starts: 
05/13/2026 - 12:00pm EDT
Event ends: 
05/13/2026 - 1:00pm EDT
Rating: 
0
Speaker(s)

Jessica Peterson, DO, FAPA

has no relevant financial relationships to disclose at this time.
Moderator(s)

Muhammad Saeed, Bcom

has no relevant financial relationships to disclose at this time.
Peer Reviewer(s)

Brandyn Powers, DO

has no relevant financial relationships to disclose at this time.

Available Credit

  • 1.00 Participation
Please login or register to take this course.